Arthrosamid injections

To treat

Pain due to arthritis in patients who want to avoid surgery.

Information

Arthrosamid is a novel and innovative injection that is different to hyaluronic acid both in its structure and in how long it remains in the joint. It uses non-biodegradable hydrogel technology, and is 97.5% water  2.5% cross linked polyacrylamide. Once injected into the joint it restores viscosity within the joint fluid, improving lubrication and cushioning the arthritic joint providing pain relief. The polyacrylamide hydrogel integrates into the synovium (the tissue lining the joint that produces joint fluid) remaining permanently.

The injection is performed with strict sterile technique under ultrasound guidance. Local anaesthetic is used to make the injection virtually pain-free. Excess joint fluid is removed and then the Arthrosamid is injected. It is a walk in walk out procedure done in the outpatient clinic. As the injection remains in the joint for many years, as part of our protocol a single antibiotic dose is given before the injection to reduce further the already very risk of infection.

Most patients notice an improvement in their pain starting about 2-3 weeks after the injection. Some notice pain relief much earlier. The improvement can last for a number of years and so a single injection is needed. A growing number of cases reported in Demark, where a huge number of injections have been performed, report many patients who are still pain free 5-8 years after their first injection.

Risks

Complications are rare. Standard risks apply. Infection. Mild soreness after the injection.

Preparation

No special preparation is needed by the patient prior to the procedure.

Appointment Duration

30 minutes

Recommended Number

Only one injection is needed as Arthrosamid has a very long duration of action measured in years rather than months.

Aftercare

A showerproof dressing is applied. This should be left in place for 24 hours. Normal activity is allowed after the injection without restriction.

Evidence

  • PROSPECTIVE STUDY OF ARTHROSAMID IN KNEE ARTHRITIS

    A single injection of Arthrosamid continued to be well-tolerated and demonstrated clinically relevant and statistically significant
    effectiveness in reducing pain at 2 years after treatment.

    Presented at OARSI (Annual Congress of OA Research International,) March 2022

  • PUBLISHED STUDY IN KNEE ARTHRITIS

    This study in a group of 84 patients showed significant reductions in pain and stiffness and improved physical function that were maintained even in the long term (1 year)

    Clin Exp Rheumat 2018 Nov-Dec;36(6):1082-1085

  • STUDY TO PROVE SAFETY OF THE INJECTION

    This study of ients found no significant incidence of adverse events or serious adverse events related to  intra-articular treatment with Arthrosamid for the relief of knee osteoarthritis pain and disability.

    Clin Ortho Adv Res J: COARJ-100001

  • OUR EXPERIENCE IN KNEE ARTHRITIS PAIN

    The injection has been launched in the UK recently and we are now monitoring our results and will share these soon.

Case Stories

Coming soon